| Product Code: ETC6896843 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Cyprus witnessed steady growth in insulin drugs & devices import shipments, with top exporters being Greece, Germany, Netherlands, Switzerland, and Vietnam. The market concentration, as measured by HHI, remained moderate, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at an impressive 10.34%, with a notable growth rate of 13.05% in 2024 alone. These trends suggest a robust market for insulin products in Cyprus, driven by diverse sources and sustained growth momentum.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Insulin Drugs & Devices Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Insulin Drugs & Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Insulin Drugs & Devices Market - Industry Life Cycle |
3.4 Cyprus Insulin Drugs & Devices Market - Porter's Five Forces |
3.5 Cyprus Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Drugs, 2021 & 2031F |
3.6 Cyprus Insulin Drugs & Devices Market Revenues & Volume Share, By Combination drugs, 2021 & 2031F |
3.7 Cyprus Insulin Drugs & Devices Market Revenues & Volume Share, By Non-Insulin Injectable drugs, 2021 & 2031F |
3.8 Cyprus Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Device, 2021 & 2031F |
4 Cyprus Insulin Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Insulin Drugs & Devices Market Trends |
6 Cyprus Insulin Drugs & Devices Market, By Types |
6.1 Cyprus Insulin Drugs & Devices Market, By Insulin Drugs |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Insulin Drugs, 2021- 2031F |
6.1.3 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Basal or Long Acting Insulins, 2021- 2031F |
6.1.4 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Bolus or Fast Acting Insulins, 2021- 2031F |
6.1.5 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Traditional Human Insulins, 2021- 2031F |
6.1.6 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Biosimilar Insulins, 2021- 2031F |
6.2 Cyprus Insulin Drugs & Devices Market, By Combination drugs |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Insulin combinations, 2021- 2031F |
6.2.3 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Oral Combinations, 2021- 2031F |
6.3 Cyprus Insulin Drugs & Devices Market, By Non-Insulin Injectable drugs |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By GLP-1 receptor agonists, 2021- 2031F |
6.3.3 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Amylin Analogue, 2021- 2031F |
6.4 Cyprus Insulin Drugs & Devices Market, By Insulin Device |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pumps, 2021- 2031F |
6.4.3 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pens, 2021- 2031F |
6.4.4 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Insulin Syringes, 2021- 2031F |
6.4.5 Cyprus Insulin Drugs & Devices Market Revenues & Volume, By Insulin Jet Injectors, 2021- 2031F |
7 Cyprus Insulin Drugs & Devices Market Import-Export Trade Statistics |
7.1 Cyprus Insulin Drugs & Devices Market Export to Major Countries |
7.2 Cyprus Insulin Drugs & Devices Market Imports from Major Countries |
8 Cyprus Insulin Drugs & Devices Market Key Performance Indicators |
9 Cyprus Insulin Drugs & Devices Market - Opportunity Assessment |
9.1 Cyprus Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Drugs, 2021 & 2031F |
9.2 Cyprus Insulin Drugs & Devices Market Opportunity Assessment, By Combination drugs, 2021 & 2031F |
9.3 Cyprus Insulin Drugs & Devices Market Opportunity Assessment, By Non-Insulin Injectable drugs, 2021 & 2031F |
9.4 Cyprus Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Device, 2021 & 2031F |
10 Cyprus Insulin Drugs & Devices Market - Competitive Landscape |
10.1 Cyprus Insulin Drugs & Devices Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Insulin Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here